New unemployment filings in Wisconsin edged higher last week, diverging from a slight national decline and highlighting ongoing labor market fluctuations across states.
A couple earning $380,000 annually faces a classic high-cost dilemma: Should they stretch for a $1.8 million dream home now or wait? With a hefty down payment saved but significant student debt, their debate highlights the tension between future earnings potential and present financial anxiety in today's premium housing markets.
Secretary-General Antonio Guterres has issued his starkest warning yet, stating the United Nations' deepening liquidity crisis threatens its operations and risks a financial meltdown, driven by unpaid dues and an antiquated budget rule.
A former investment advisor with ties to major Wall Street firms has been sentenced to six years behind bars for orchestrating a million-dollar fraud scheme, using client funds to finance a luxury lifestyle that included high-end cars and country club memberships.
President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank has ignited market speculation over the future path of interest rates, with analysts divided on whether his leadership would mean more cuts or a return to hawkish restraint.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
Meta Platforms announces a 10% workforce reduction in its Reality Labs division, signaling a strategic shift away from its massive metaverse investments toward artificial intelligence and augmented reality, raising questions about the company's future profitability and stock performance.
Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.
A pivotal week in business saw Tesla's long-awaited robotaxis begin operations without safety drivers, signaling a new phase in autonomous mobility. Meanwhile, Greg Abel's early moves at Berkshire Hathaway hint at a potential strategic shift, and a push for tokenized, round-the-clock stock trading raises questions about the future of finance.
The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.
The thrill of the hunt for luxury bargains is fading for American shoppers as Saks Global closes dozens of off-price physical stores. Experts explain the deep-seated psychology behind bargain hunting and what the retail landscape loses with these closures.
President Trump's nomination of Kevin Warsh to lead the Federal Reserve has sent ripples through cryptocurrency markets, as traders assess the implications of a governor with direct crypto investment experience and a hawkish monetary policy reputation.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
A pair of aviator sunglasses worn by French President Emmanuel Macron during a high-profile moment at Davos has triggered a global sales frenzy for the historic brand Henry Jullien. While the Italian-owned company sees its stock and orders surge, industry veterans question whether the presidential spotlight can stem the long-term decline of French eyewear manufacturing.
South African low-cost carrier Lift has secured membership in the International Air Transport Association (IATA), a key milestone that validates its business model and facilitates its planned regional expansion into Mauritius and Reunion.
As copper prices surge over 40% since August, driven by supply constraints and green energy demand, investors are eyeing major producers BHP, Freeport-McMoRan, and Southern Copper, each offering a distinct path to exposure in the red-hot market.
South Africa ordered Israel's top diplomat to leave the country within 72 hours on Friday, citing a "series of violations" and prompting the Israeli government to expel Pretoria's own diplomatic representative.The Israeli foreign ministry swiftly responded that South Africa's senior diplomatic representative, Shaun Byneveldt, "is persona non grata and must leave Israel within 72 hours".
U.S. stock futures turned lower Friday morning following President Trump's announcement nominating former Fed Governor Kevin Warsh to chair the Federal Reserve, replacing Jerome Powell. The move injects fresh uncertainty into monetary policy outlook.
Shares of Corcept Therapeutics plunged 16% after a corrected FDA letter disclosed the agency had repeatedly cautioned the company against filing its application for a Cushing's syndrome drug, which was later rejected over efficacy and safety concerns.
New unemployment filings in Maryland fell significantly last week, offering a spot of positive news for the state's labor market as national claims also edged lower.
